Bio Essence (BIOE) Total Current Liabilities (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Total Current Liabilities of $2.2 million in Q1 2026, down 11.41% quarter-over-quarter from $2.4 million in Q4 2025, and down 33.28% on a YoY basis from $3.2 million in Q1 2025.
Bio Essence (BIOE) Total Current Liabilities (2020 - 2026) Analysis & Trends
Bio Essence's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 33.28% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 33.28% YoY), while the FY2025 annual figure was $2.4 million, down 12.97% from the prior year.
- Total Current Liabilities was $2.2 million for Q1 2026 at Bio Essence, down from $2.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $3.8 million in Q1 2023 to a low of $1.5 million in Q2 2023.
- Historically, Total Current Liabilities has averaged $2.9 million across 5 years, with a median of $3.1 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities tumbled 52.53% in 2023, then jumped 104.2% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $3.6 million in 2022, then tumbled by 31.12% to $2.5 million in 2023, then increased by 14.37% to $2.8 million in 2024, then declined by 12.97% to $2.4 million in 2025, then declined by 11.41% to $2.2 million in 2026.
- The last three Total Current Liabilities figures came in at $2.2 million (Q1 2026), $2.4 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | 2.92 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 3.78 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 3.21 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | 2.76 Mn |
| Sep 30, 2021 | 2.70 Mn |
| Jun 30, 2021 | 2.47 Mn |